Selangor Saring Precision Screening
Hayat Technologies Sdn Bhd
(
Private sector
)
#SDGAction53494
Description
This is an AI-powered digital tool designed to optimise the precision of non-communicable disease (NCD) screening and improve program outcomes. Built-in risk stratification algorithms and multi-level health system integration allows for a reduction in unnecessary repetitive screening cost, targeted allocation of screening slots, and better profiling at detecting undiagnosed non-communicable disease cases, in comparison with current conservative methods of relying on individual self-declaration of risk factors.
A little backgrounder: NCD and cancer are a silent pandemic, whose prevalence is increasing worldwide. The Selangor state government in Malaysia has a policy of early screening, early diagnosis, and early treatment to combat these diseases. So, a free health screening program, Selangor Saring, was conducted across the state, targeting high-risk citizens.
In Selangor Saring, the targeted diseases are diabetes, hypertension, cardiovascular disease, chronic kidney disease, breast cancer, colorectal cancer, prostate cancer and cervical cancer.
To optimise efficiency, this tool uses the digital health platform Selangkah, allowing for precision screening through user risk profiling. Predictive risk profiling helped boost turnout to 70% and positive yield to 65%, and reduced follow-up loss to 30%, surpassing the national benchmarks of 30%, 40%, and 80% respectively.
The Selangor Saring health screening program is a complete ecosystem starting from pre-registration and sampling collection to result transmission and the option to follow up. So far, our list of partners are government and private medical practitioner, members of the public, stakeholders and NGOs.
The Selangor state government is committed to continue this program for the next five years.
Essentially, the tool aims to empower individuals to take control of their health and detect potential health issues early on, enabling them to make lifestyle changes and seek medical treatment if necessary. Early detection and management of diseases can help prevent complications and improve the users' health outcomes.
The Selangor Saring Precision Tool is a complete ecosystem comprising pre-registration, sampling collection, results transmission and option to undergo follow-up treatments.
1. Pre-Registration
- Each participant will need to register through Selangkah App where they are required to answer a questionnaire to determine which screenings, they are eligible for. The screening coupons can then be redeemed at the onsite screening location.
- Selangor Saring involves personal data, so it is compulsory for each participant to go through an e-KYC process during registration. This is done digitally and there is no need for physical documentation other than their identification card.
2. Sampling Collection
- Once a participant has completed their screenings on site, their samples will be sent to the participating pathology labs to be analysed. Here, participants will be diagnosed and determined if they suffer from any of the targeted diseases.
3. Result transmission
- Lab reports will be submitted to the Selangkah backend team, who will then share it with the respective participants via the Selangkah App.
4. Option to Follow Up
Selangor Saring doesn’t just end there. Each participant with abnormal results will be given the opportunity to do a follow-up check-up at the participating clinics and hospital of their choice. Without early screening, we wouldn’t know whether how healthy we are especially with the sedentary lifestyle we are leading today.
Selangkah Ventures Sdn Bhd, SelCare Corporation
SDGS & Targets
Goal 3
Ensure healthy lives and promote well-being for all at all ages
3.1
3.1.1
Maternal mortality ratio
3.1.2
Proportion of births attended by skilled health personnel
3.2
3.2.1
Under-five mortality rate
3.2.2
Neonatal mortality rate
3.3
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
3.3.1
Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations
3.3.2
Tuberculosis incidence per 100,000 population
3.3.3
Malaria incidence per 1,000 population
3.3.4
Hepatitis B incidence per 100,000 population
3.3.5
Number of people requiring interventions against neglected tropical diseases
3.4
3.4.1
Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
3.4.2
Suicide mortality rate
3.5
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
3.5.1
Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders
3.5.2
Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol
3.6
3.6.1
Death rate due to road traffic injuries
3.7
By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
3.7.1
Proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods
3.7.2
Adolescent birth rate (aged 10-14 years; aged 15-19 years) per 1,000 women in that age group
3.8
Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
3.8.1
Coverage of essential health services
3.8.2
Proportion of population with large household expenditures on health as a share of total household expenditure or income
3.9
3.9.1
Mortality rate attributed to household and ambient air pollution
3.9.2
Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)
3.9.3
Mortality rate attributed to unintentional poisoning
3.a
3.a.1
Age-standardized prevalence of current tobacco use among persons aged 15 years and older
3.b
Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3.b.1
Proportion of the target population covered by all vaccines included in their national programme
3.b.2
3.b.3
Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis
3.c
3.c.1
Health worker density and distribution
3.d
Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks
3.d.1
International Health Regulations (IHR) capacity and health emergency preparedness
3.d.2
Percentage of bloodstream infections due to selected antimicrobial-resistant organisms
SDG 14 targets covered
| Name | Description |
|---|
Deliverables & Timeline
Resources mobilized
Partnership Progress
Feedback
Action Network
Type of initiative
Share
Timeline
Entity
SDGs
Geographical coverage
Other beneficiaries
High-risk citizens living in the state of Selangor, Malaysia.
More information
Countries
Contact Information
, Chief Executive Officer